Fig. 6 | Scientific Reports

Fig. 6

From: Preclinical and clinical evaluation of [64Cu]Cu-PSMA-Q PET/CT for prostate cancer detection and its comparison with [18F]FDG imaging

Fig. 6

MIP images of PET examinations with [64Cu]Cu-PSMA-Q (A) and [18F]FDG (B) and axial PET/CT for [64Cu]Cu-PSMA-Q (C) and [18F]FDG (D) in a 74-year-old patient with a PSA of 374 ng/ml with positive biopsy, Gleason score 9 [5 + 4], and treatment-naive. (C) [64Cu]Cu-PSMA-Q PET/CT showed multifocal PSMA-positive lesions in the prostate (red arrow, SUVmax 57.3) and adjacent rectal invasion thickened (blue arrow SUVmax 21.9). (D) [18F]FDG PET/CT showed a focal positive prostate lesion (SUVmax 4.4) with no radioactive concentration in the adjacent thickened rectum.

Back to article page